-
1 Comment
Cawachi Limited is currently in a long term downtrend where the price is trading 20.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Cawachi Limited's total revenue rose by 3.3% to $68B since the same quarter in the previous year.
Its net income has increased by 81.3% to $2B since the same quarter in the previous year.
Based on the above factors, Cawachi Limited gets an overall score of 3/5.
| ISIN | JP3226450009 |
|---|---|
| Exchange | TSE |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Beta | -0.09 |
|---|---|
| Dividend Yield | 5.8% |
| Market Cap | 66B |
| PE Ratio | 14.14 |
| Target Price | None |
Cawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, which includes cold medicines, gastrointestinal medicines, vitamins, eye drops, trauma medicines, health food, nursing care products, and dispensing products; cosmetics; general merchandise, including hair care products, oral care products, detergents, papers, pet products, and childcare products; and general food products, such as processed foods, daily items, sweets, beverages, and alcohol. It also involved in the insurance business. The company was founded in 1967 and is headquartered in Oyama, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2664.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
